Journal article
Common Drug Review Recommendations
Abstract
Background: The Common Drug Review (CDR) was created to provide a single process to review the comparative clinical efficacy and cost effectiveness of new drugs, and then to make formulary listing recommendations to Canadian publicly funded drug benefit plans.Objective: The objective was to conduct an in-depth analysis of Canadian Expert Drug Advisory Committee (CEDAC) recommendations to date, to explore predictors and possible explanatory …
Authors
Rocchi A; Miller E; Hopkins RB; Goeree R
Journal
PharmacoEconomics, Vol. 30, No. 3, pp. 229–246
Publisher
Springer Nature
Publication Date
March 2012
DOI
10.2165/11593030-000000000-00000
ISSN
1170-7690